Literature DB >> 15953917

Oral effects of low-dose methotrexate treatment.

Athanasios Kalantzis1, Zoe Marshman, Denis T Falconer, Peter R Morgan, Edward W Odell.   

Abstract

Methotrexate is used increasingly in low-dose regimes for a variety of conditions, particularly rheumatoid arthritis. While certain adverse effects of low-dose methotrexate have been described in detail, oral complications have received little attention. This article includes a summary of the uses and pharmacology of low-dose methotrexate and the mechanisms that lead to general and oral toxicity. The literature relevant to potential oral adverse effects is discussed and 7 illustrative cases are presented. The oral effects noted range from nonhealing ulcers to lymphoma-like lesions. Dental practitioners should be aware of the possible oral effects of low-dose methotrexate that have so far been largely unrecognized.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15953917     DOI: 10.1016/j.tripleo.2004.08.020

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod        ISSN: 1079-2104


  14 in total

Review 1.  Three decades of low-dose methotrexate in rheumatoid arthritis: can we predict toxicity?

Authors:  Vasco C Romão; Aurea Lima; Miguel Bernardes; Helena Canhão; João Eurico Fonseca
Journal:  Immunol Res       Date:  2014-12       Impact factor: 2.829

Review 2.  Oral pathology in inflammatory bowel disease.

Authors:  Miranda Muhvić-Urek; Marija Tomac-Stojmenović; Brankica Mijandrušić-Sinčić
Journal:  World J Gastroenterol       Date:  2016-07-07       Impact factor: 5.742

3.  [Methotrexate toxicity. Myths and facts].

Authors:  G Keysser
Journal:  Z Rheumatol       Date:  2011-02       Impact factor: 1.372

4.  Investigating methotrexate toxicity within a randomized double-blinded, placebo-controlled trial: Rationale and design of the Cardiovascular Inflammation Reduction Trial-Adverse Events (CIRT-AE) Study.

Authors:  Jeffrey A Sparks; Medha Barbhaiya; Elizabeth W Karlson; Susan Y Ritter; Soumya Raychaudhuri; Cassandra C Corrigan; Fengxin Lu; Jacob Selhub; Daniel I Chasman; Nina P Paynter; Paul M Ridker; Daniel H Solomon
Journal:  Semin Arthritis Rheum       Date:  2017-02-10       Impact factor: 5.532

5.  EBV-Positive B-Cell Proliferations of Varied Malignant Potential: 2015 SH/EAHP Workshop Report-Part 1.

Authors:  Yasodha Natkunam; John R Goodlad; Amy Chadburn; Daphne de Jong; Dita Gratzinger; John K C Chan; Jonathan Said; Elaine S Jaffe
Journal:  Am J Clin Pathol       Date:  2017-02-01       Impact factor: 2.493

6.  Epstein-Barr virus-positive ulcer in the oral cavity.

Authors:  Jose David Ramos-Baena; Luis Fernando Jacinto-Alemán; Elba Rosa Leyva-Huerta; Javier Portilla-Robertson
Journal:  J Oral Maxillofac Pathol       Date:  2021-03-19

7.  Methotrexate-induced pneumonitis in Crohn's disease. Case report and review of the literature.

Authors:  Nadia D'Andrea; Luca Triolo; Giovanna Margagnoni; Annalisa Aratari; Claudio M Sanguinetti
Journal:  Multidiscip Respir Med       Date:  2010-10-31

8.  Oral manifestations of T-cell large granular lymphocytic leukemia: a case report.

Authors:  Ioanna-Eirini Arvanitidou; Nikolaos G Nikitakis; Alexandra Sklavounou
Journal:  J Oral Maxillofac Res       Date:  2011-10-01

9.  In vitro inhibition of HUVECs by low dose methotrexate - insights into oral adverse events.

Authors:  Tobias Annussek; Thomas Szuwart; Johannes Kleinheinz; Cathrin Koiky; Kai Wermker
Journal:  Head Face Med       Date:  2014-05-22       Impact factor: 2.151

10.  Atypical methotrexate ulcerative stomatitis with features of lymphoproliferative like disorder: Report of a rare ciprofloxacin-induced case and review of the literature.

Authors:  Nikolaos Katsoulas; Evanthia Chrysomali; Evangelia Piperi; Georgia Levidou; Alexandra Sklavounou-Andrikopoulou
Journal:  J Clin Exp Dent       Date:  2016-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.